The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia - Third Edition

Sep 29, 2026

Uploaded by Dipper

American Psychiatric Association practice guideline for treating patients with schizophrenia, third edition, providing structured recommendations for assessment, treatment planning, and implementation. The guideline presents an overview of the development process, including how guideline statements are rated and how supporting research evidence is assessed. It covers proper use of guidelines, summaries of guideline statements, and detailed guidance on key statements such as assessment of possible schizophrenia and use of quantitative measures.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages312

Reading Time13 h 6 min

AccessFree to download

Acronyms/Abbreviations

Introduction

Rationale

Scope of Document

Overview of the Development Process

Rating the Strengths of Guideline Statements and Supporting Research Evidence

Proper Use of Guidelines

Guideline Statement Summary

Guideline Statements and Implementation

Assessment and Determination of Treatment Plan

Statement 1 : Assessment of Possible Schizophrenia

Implementation

Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement

Review of Available Guidelines From Other Organizations

Quality Measurement Considerations

Statement 2 : Use of Quantitative Measures

Implementation

THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE GUIDELINE FOR THE Treatment of Patients With Schizophrenia T H I R D E D I T I O N THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE GUIDELINE FOR THE Treatment of Patients With Schizophrenia THIRD EDITION Guideline Writing Group George A. Keepers, M.D. , Chair Laura J. Fochtmann, M.D. , M.B.I. , Vice-Chair; Methodologist Joan M. Anzia, M. D. Sheldon Benjamin, M. D. Jeffrey M. Lyness, M.D. Ramin Mojtabai, M.D. Mark Servis, M. D. Art Walaszek, M. D. Peter Buckley, M.D. Mark F. Lenzenweger, Ph.D. Alexander S. Young, M.D. , M.S.H.S. Amanda Degenhardt, M.D. Systematic Review Group Laura J. Fochtmann, M.D. , M.B.I. , Methodologist Seung-Hee Hong Committee on Practice Guidelines Daniel J. Anzia, M. D. , Chair R. Scott Benson, M. D. Thomas J. Craig, M.D. Catherine Crone, M. D. Annette L. Hanson, M. D. John M. Oldham, M. D. Carlos N. Pato, M. D. , Ph. D. Michael J. Vergare, M.D. Joel Yager, M.D. , Consultant Laura J. Fochtmann, M. D. , M. B. I. , Consultant APA Assembly Liaisons Daniel Dahl, M. D. Bhasker Dave, M. D. Evan Eyler, M.D. Annette L. Hanson, M. D. Jason W. Hunziker, M. D. Marvin Koss, M. D. Robert M. McCarron, D.O. John P. D. Shemo, M. D. APA wishes to acknowledge the contributions of APA staff and former staff (Jennifer Medicus, Seung-Hee Hong, Samantha Shugarman, Michelle Dirst, Kristin Kroeger Ptakowski) . APA also wishes to acknowledge the contribution of Amanda S. Eloma, Pharm.D., BCPP, in reviewing information related to medications in the guideline and associated tables. In addition, APA and the Guideline Writing Group especially thank Laura J. Fochtmann, M.D., M.B.I.; Seung-Hee Hong; and Jennifer Medicus for their outstanding work and effort in developing this guideline. APA also thanks the APA Committee on Practice Guidelines (Daniel J. Anzia, M.D., Chair), liaisons from the APA Assembly for their input and assistance, and APA Councils and others for providing feedback during the comment period. The authors have worked to ensure that all information in this book is accurate at the time of publication and consistent with general psychiatric and medical standards. As medical research and practice continue to advance, however, therapeutic standards may change. Moreover, specific situations may require a specific therapeutic response not included in this book. For these reasons and because human and mechanical errors sometimes occur, we recommend that readers follow the advice of physicians directly involved in their care or the care of a member of their family. For inquiries about permissions or licensing, please contact Permissions & Licensing, American Psychiatric Association Publishing, 800 Maine Avenue SW, Suite 900, Washington, DC 20024-2812 or submit inquiries on[line at: www.appi.org/Support/Customer-Information/Permissions](line at: www.appi.org/Support/Customer-Information/Permissions). If you wish to buy 50 or more copies of the same title, [please go to www.appi.org/specialdiscounts](please go to www.appi.org/specialdiscounts) for more information. Copyright © 2021 American Psychiatric Association ALL RIGHTS RESERVED Third Edition Manufactured in the United States of America on acid-free paper 24 23 22 21 20 5 4 3 2 1 American Psychiatric Association 800 Maine Avenue SW Suite 900 Washington, DC 20024-2812 [www.appi.org](www.appi.org) Library of Congress Cataloging-in-Publication Data Names: American Psychiatric Association, author, issuing body. Title: The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia / Guideline Writing Group, Systematic Review Group, Committee on Practice Guidelines. Other titles: Treatment of patients with schizophrenia Description: Third edition. | Washington, DC : American Psychiatric Association,[2021] | Preceded by: Practice guideline for the treatment of patients with sch

FAQs

What is the document’s purpose?

It provides a practice guideline for the treatment of patients with schizophrenia, including recommendations for assessment, treatment planning, and implementation.

How does the guideline describe its development process?

It includes an overview of the development process and explains how guideline statements’ strengths and supporting research evidence are rated.

Which early topics are covered in the guideline contents?

The contents list areas such as proper use of guidelines, guideline statement summary, and specific statements including assessment of possible schizophrenia and use of quantitative measures.

Sep 29, 2026

Uploaded by Dipper